Pesquisar
AbbVie Inc
ABBVAdicionar à lista de desejos
248.050USD
-0.030-0.01%
Fechamento 07/13, 16:00（ET）Cotações atrasadas em 15 min
438.16BValor de mercado
122.10P/L TTM
Mais detalhes de AbbVie Inc Empresa
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).
Informações de AbbVie Inc
Código da empresaABBV
Nome da EmpresaAbbVie Inc
Data de listagemJan 02, 2013
CEOMichael (Robert A)
Número de funcionários55000
Tipo de títulosOrdinary Share
Fim do ano fiscalJan 02
Endereço1 N Waukegan Rd
CidadeNORTH CHICAGO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal60064
Telefone18479327900
Sitehttps://www.abbvie.com/
Código da empresaABBV
Data de listagemJan 02, 2013
CEOMichael (Robert A)
Executivos da empresa AbbVie Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Azita Saleki-Gerhardt, Ph.D.
Dr. Azita Saleki-Gerhardt, Ph.D.
Executive Vice President, Chief Operations Officer
Executive Vice President, Chief Operations Officer
204.37K
+0.05%
Mr. Thomas C. (Tom) Freyman, CPA
Mr. Thomas C. (Tom) Freyman, CPA
Independent Director
Independent Director
135.75K
+0.82%
Dr. Roopal Thakkar, M.D.
Dr. Roopal Thakkar, M.D.
Executive Vice President - Research & Development, Chief Scientific Officer
Executive Vice President - Research & Development, Chief Scientific Officer
55.37K
+5.41%
Mr. Edward J. (Ed) Rapp
Mr. Edward J. (Ed) Rapp
Independent Director
Independent Director
45.96K
+2.43%
Ms. Roxanne S. Austin, CPA
Ms. Roxanne S. Austin, CPA
Lead Independent Director
Lead Independent Director
39.58K
+2.82%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
35.65K
--
Mr. Frederick H. (Rick) Waddell
Mr. Frederick H. (Rick) Waddell
Independent Director
Independent Director
30.08K
+3.72%
Ms. Melody B. Meyer
Ms. Melody B. Meyer
Independent Director
Independent Director
17.62K
+6.35%
Mr. Timothy J. Richmond
Mr. Timothy J. Richmond
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
6.13K
-346.66%
Mr. Thomas J. (Tom) Falk
Mr. Thomas J. (Tom) Falk
Independent Director
Independent Director
5.32K
+21.01%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Azita Saleki-Gerhardt, Ph.D.
Dr. Azita Saleki-Gerhardt, Ph.D.
Executive Vice President, Chief Operations Officer
Executive Vice President, Chief Operations Officer
204.37K
+0.05%
Mr. Thomas C. (Tom) Freyman, CPA
Mr. Thomas C. (Tom) Freyman, CPA
Independent Director
Independent Director
135.75K
+0.82%
Dr. Roopal Thakkar, M.D.
Dr. Roopal Thakkar, M.D.
Executive Vice President - Research & Development, Chief Scientific Officer
Executive Vice President - Research & Development, Chief Scientific Officer
55.37K
+5.41%
Mr. Edward J. (Ed) Rapp
Mr. Edward J. (Ed) Rapp
Independent Director
Independent Director
45.96K
+2.43%
Ms. Roxanne S. Austin, CPA
Ms. Roxanne S. Austin, CPA
Lead Independent Director
Lead Independent Director
39.58K
+2.82%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
35.65K
--
Perguntas frequentes
Quem são os cinco principais acionistas de AbbVie Inc?
Os cinco principais acionistas de AbbVie Inc são: Dr. Azita Saleki-Gerhardt, Ph.D.
Quantas instituições possuem ações da AbbVie Inc (ABBV)?
Em 2026Q1, 5703 instituições possuíam ações da AbbVie Inc, com valor de mercado aproximado de 1.36B, representando 77.09% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 26641628.00.
Qual é a maior fonte de receita da AbbVie Inc?
Em 2026Q1, o segmento de negócios Immunology-SKYRIZI gerou a maior receita para AbbVie Inc, totalizando 17.56B e representando 28.71% da receita total.